Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

-Ahead of print
-Authors' Accepted
    Manuscripts
new!
-Current Issue
-Archive
-Acknowledgments
-Special Issues
-Browse by Category

Manuscript Submission

-Online Submission
-Online Review
-Instruction for Authors
-Instruction for Reviewers
-English Corner new!

About AJA

-About AJA
-Editorial Board
-Contact Us
-News

Resources & Services

-Advertisement
-Subscription
-Email alert
-Proceedings
-Reprints

Download area

-Copyright licence
-EndNote style file
-Manuscript word template
-Guidance for AJA figures
    preparation (in English)

-Guidance for AJA figures
    preparation (in Chinese)

-Proof-reading for the
    authors

-AJA Club (in English)
-AJA Club (in Chinese)

 
Abstract

Volume 15, Issue 4 (July 2013) 15, 449–450; 10.1038/aja.2013.63

A tight junction between E-Cadherin and the prostate tumor suppressor SPDEF

Valeria Coppola and Désirée Bonci

Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome 00161, Italy

Correspondence: Dr V Coppola, (valeria.coppola@iss.it)

advance online publication, May 27, 2013

Abstract

Mounting evidence is highlighting the role of the ETS factor SPDEF as a prostate tumor suppressor. In a recent paper by Pal et al., SPDEF was found to transcriptionally control the expression of E-Cadherin, an adhesion molecule with a crucial role in preventing metastatic spread.

PDF | PDF |

 
Browse:  4085
 
Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X  Copyright © 2023  Shanghai Materia Medica, Chinese Academy of Sciences.  All rights reserved.